In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
À_SOMBRA mycelium burial urn embraces ecological regeneration
In Brazil, the À_SOMBRA project has added a new eco-friendly end-of-life option. Designed by João Pedro Alves Cavalcanti and Jeanine Torres Geammal from the...
Shadow puppet art exhibit swaps animal leather for kombucha byproduct
In India, kombucha byproduct is being used to produce sustainable leather for shadow puppet exhibit Luminous Lore.
The exhibit aims to showcase Tholu Bommalata,...
Save the sturgeon with Umami Bioworks cultivated caviar
In Singapore, Umami Bioworks has unveiled cultivated caviar made from a mix of cultured sturgeon cells and plant-based ingredients.
The caviar alternative addresses many...